AZTANasdaqSpecial Industry Machinery, NECFiscal year ends September 30
Azenta, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$34.84+0.75 (+2.20%)
Close on Oct 19, 2026
- Market cap
- $1.58B
- P/E (TTM)
- –
- Dividend yield
- –
Azenta, Inc. revenue by segment
By business segment
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Management Solutions | $336.82M | $326.15M | $324.88M | $324.59M | $323.66M | $326.71M | $321.03M | $318.90M | $315.17M | $309.84M | $306.74M | $303.19M | 54.9% | +4.1% |
| Multiomics | $276.99M | $270.33M | $270.15M | $269.23M | $262.05M | $259.43M | $258.13M | $254.55M | $249.68M | $249.91M | $249.93M | $248.30M | 45.1% | +5.7% |
| Core Products | $194.04M | $192.03M | $195.61M | $197.63M | $196.51M | $200.29M | $197.24M | $196.50M | $195.85M | $194.22M | – | $192.06M | 31.6% | -1.3% |
| Sample Repository Services | $142.78M | $134.13M | $129.26M | $126.96M | $127.15M | $126.42M | $123.79M | $122.39M | $119.32M | $115.62M | – | $111.13M | 23.3% | +12.3% |
| Life Sciences Products | – | – | – | – | – | – | – | – | – | – | – | $305.18M | – | – |
| Life Sciences Services | – | – | – | – | – | – | – | – | – | – | – | $359.89M | – | – |
| B Medical Systems S.a.r.l. [Member] | – | – | – | – | – | – | – | $83.13M | – | – | – | $113.12M | – | – |
| Operating income | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Management Solutions | $22.27M | $28.06M | $27.76M | $27.55M | $27.91M | $20.76M | $16.49M | $11.11M | $7.48M | $4.71M | $89.00K | -$2.29M | -20.2% |
| Multiomics | -$14.91M | -$18.52M | -$13.99M | -$11.94M | -$12.80M | -$9.44M | -$6.78M | -$7.73M | -$9.59M | -$12.41M | -$13.34M | -$13.34M | +16.5% |
| Life Sciences Products | – | – | – | – | – | – | – | – | – | – | – | -$30.32M | – |
| Life Sciences Services | – | – | – | – | – | – | – | – | – | – | – | -$14.72M | – |
| B Medical Systems S.a.r.l. [Member] | – | – | – | – | – | – | – | -$5.67M | – | – | – | $919.00K | – |
By product or service
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | $445.80M | $430.35M | $424.58M | $420.63M | $412.85M | $408.65M | $404.85M | $399.73M | $384.02M | $382.41M | $381.31M | $375.39M | 72.6% | +8.0% |
| Products | $168.01M | $166.13M | $170.45M | $173.19M | $172.38M | $177.02M | $173.84M | $173.72M | $198.69M | $221.96M | $235.10M | $176.10M | 27.4% | -2.5% |
By region
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $355.74M | $352.04M | $358.95M | $365.00M | $363.38M | $370.60M | $368.40M | $365.05M | $360.82M | $354.98M | – | $351.41M | 58.0% | -2.1% |
| Rest of Europe | $114.72M | $110.16M | $109.55M | $107.37M | $103.67M | $99.61M | $96.74M | $95.15M | $69.25M | $71.46M | – | $87.19M | 18.7% | +10.7% |
| China | $70.02M | $65.55M | $61.39M | $58.35M | $57.14M | $57.33M | $58.23M | $58.24M | $56.28M | $55.29M | $53.62M | $52.13M | 11.4% | +22.5% |
| United Kingdom | $42.83M | $40.04M | $37.65M | $35.39M | $32.85M | $31.64M | $29.25M | $27.20M | $26.11M | $26.76M | $26.92M | $26.66M | 7.0% | +30.4% |
| Other | $4.95M | $4.29M | $4.23M | $4.43M | – | – | – | – | – | – | – | – | 0.8% | – |
| North America | – | – | – | – | – | – | – | – | – | $361.99M | $360.16M | $359.42M | – | – |
| Asia / Pacific / Other | – | – | – | – | – | – | – | – | – | $44.53M | $49.88M | $52.16M | – | – |
| Africa [Member] | – | – | – | – | – | – | – | $61.96M | $68.64M | $65.71M | $55.39M | $65.09M | – | – |
| Asia Pacific [Member] | – | – | $21.93M | $23.28M | $20.82M | $19.12M | $18.68M | $21.32M | $35.96M | $42.53M | – | $25.63M | – | – |
From the segment and revenue-disaggregation notes of Azenta's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.